Hypertension management takes centre stage in Nigeria
TOWARDS ensuring the availability of affordable medicines for sustained management of hypertension among Nigerians, Aprovasc, a fixed-dose combination treatment was recently introduced from the stable of Sanofi Nigeria. Introduction of the new drug, combined with the continual support of establishing clinics for the better management of the disease, is in direct response to the healthcare needs of patients with hypertension in Nigeria.

